Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice

H Huang, S Xiao, J Qin, Y Jiang, S Yang, T Li, Y Gao… - Archives of …, 2011 - Springer
A pseudotype baculovirus with the glycoprotein of vesicular stomatitis virus (VSV-G) on the
envelope was used as a vector for the construction of recombinant baculovirus expressing …

Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model

Q Wu, F Yu, J Xu, Y Li, H Chen, S Xiao, ZF Fu… - Veterinary …, 2014 - Elsevier
Rabies virus has been an ongoing threat to humans and animals. Here, we developed a
new strategy to generate a rabies virus vaccine based on a pseudotyped baculovirus. The …

A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection

HD Foley, JP McGettigan, CA Siler… - Proceedings of the …, 2000 - National Acad Sciences
To investigate the importance of the rabies virus (RV) glycoprotein (G) in protection against
rabies, we constructed a recombinant RV (rRV) in which the RV G ecto-and transmembrane …

Virus-like vesicles based on Semliki forest virus-containing rabies virus glycoprotein make a safe and efficacious rabies vaccine candidate in a mouse model

C Zhang, Y Tian, C Chen, Z Wang, J Pei, C Lin… - Journal of …, 2021 - Am Soc Microbiol
Rabies is a fatal zoonosis that causes encephalitis in mammals, and vaccination is the most
effective method to control and eliminate rabies. Virus-like vesicles (VLVs), which are …

Using rabies virus vaccine strain SRV9 as viral vector to express exogenous gene

H Wang, H Jin, N Feng, X Zheng, L Li, Y Qi, M Liang… - Virus genes, 2015 - Springer
Rabies virus (RABV) can cause a fatal neurological disease in human and animals, and
vaccines were generally applied for the immunoprophylaxis of rabies. Here, a recombinant …

High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector

K Morimoto, MJ Schnell, R Pulmanausahakul… - Journal of …, 2001 - Elsevier
Humans exposed to rabies virus must be promptly treated by passive immunization with anti-
rabies antibody and active immunization with rabies vaccine. Currently, antibody prepared …

In vitro and in vivo gene delivery by recombinant baculoviruses

H Tani, CK Limn, CC Yap, M Onishi, M Nozaki… - Journal of …, 2003 - Am Soc Microbiol
Although recombinant baculovirus vectors can be an efficient tool for gene transfer into
mammalian cells in vitro, gene transduction in vivo has been hampered by the inactivation of …

Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice

JE Park, HJ Shin - Veterinary Quarterly, 2021 - Taylor & Francis
Background Rabies is a viral disease that causes severe neurological manifestations both in
humans and various mammals. Although inactivated and/or attenuated vaccines have been …

Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses

Y Kitagawa, H Tani, CK Limn, TM Matsunaga… - Journal of …, 2005 - Am Soc Microbiol
The baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) can infect
a variety of mammalian cells, as well as insect cells, facilitating its use as a viral vector for …

New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection

AK Grabowska, AD Lipińska, J Rohde, B Szewczyk… - Vaccine, 2009 - Elsevier
The present study demonstrates the protective potential of novel baculovirus recombinants,
which express the glycoproteins gB, gC, or gD of Pseudorabies virus (PRV; …